Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis

Journal of Biological Chemistry

Volumn 287, Issue 48, 2012, Pages 40339-40349

  Diamantopoulou, Zoi ^a   Kitsou, Paraskevi ^a   Menashi, Suzanne ^b   Courty, Jose ^b   Katsoris, Panagiotis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b Université Paris Est ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MIGRATION; GROWTH FACTOR; NUDE MICE; PLEIOTROPHIN; PROSTATE CANCER CELLS; PROSTATE CANCERS; PROSTATE CARCINOMA; RECEPTOR PROTEINS; SIGNAL TRANSDUCTION PATHWAYS; TUMOR DEVELOPMENT; TUMOR METASTASIS;

AMINO ACIDS; CELL CULTURE; DISEASES; PHOSPHATASES; PROTEINS; SIGNAL TRANSDUCTION; TUMORS;

PATHOLOGY;

FOCAL ADHESION KINASE; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLEIOTROPHIN; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE BETA; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ZETA; SYNDECAN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, NUDE; NEOPLASM METASTASIS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; SIGNAL TRANSDUCTION; SYNDECAN-3; UP-REGULATION;

MUS MUSCULUS;

EID: 84870011791     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.405852     Document Type: Article

References (56)

1. Li, Y. S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J., and Deuel, T. F. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250, 1690-1694 (Pubitemid 120031872)
2. Rauvala, H. (1989) An 18-kDa heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J. 8, 2933-2941
3. Milner, P. G., Li, Y. S., Hoffman, R. M., Kodner, C. M., Siegel, N. R., and Deuel, T. F. (1989) A novel 17 kDa heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem. Biophys. Res. Commun. 165, 1096-1103 (Pubitemid 20029821)
4. Courty, J., Dauchel, M. C., Caruelle, D., Perderiset, M., and Barritault, D. (1991) Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem. Biophys. Res. Commun. 180, 145-151
5. Jäger, R., Noll, K., Havemann, K., Pflüger, K. H., Knabbe, C., Rauvala, H., and Zugmaier, G. (1997) Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines. Int. J. Cancer 73, 537-543 (Pubitemid 28005318)
6. Klomp, H. J., Zernial, O., Flachmann, S., Wellstein, A., and Juhl, H. (2002) Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin. Cancer Res. 8, 823-827 (Pubitemid 34742114)
7. Wu, H., Barusevicius, A., Babb, J., Klein-Szanto, A., Godwin, A., Elenitsas, R., Gelfand, J. M., Lessin, S., and Seykora, J. T. (2005) Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J. Cutan. Pathol. 32, 125-130 (Pubitemid 40216048)
8. Müller, S., Kunkel, P., Lamszus, K., Ulbricht, U., Lorente, G. A., Nelson, A. M., von Schack, D., Chin, D. J., Lohr, S. C., Westphal, M., and Melcher, T. (2003) A role for receptor tyrosine phosphatase ζ in glioma cell migration. Oncogene 22, 6661-6668 (Pubitemid 37372206)
9. Ulbricht, U., Brockmann, M. A., Aigner, A., Eckerich, C., Müller, S., Fillbrandt, R., Westphal, M., and Lamszus, K. (2003) Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J. Neuropathol. Exp. Neurol. 62, 1265-1275 (Pubitemid 37494195)
10. Zhang, L., Mabuchi, T., Satoh, E., Maeda, S., Nukui, H., and Naganuma, H. (2004) Overexpression of heparin-binding growth-associated molecule in malignant glioma cells. Neurol. Med. Chir. 44, 637-643 (Pubitemid 40040644)
11. Vacherot, F., Caruelle, D., Chopin, D., Gil-Diez, S., Barritault, D., Caruelle, J. P., and Courty, J. (1999) Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate 38, 126-136 (Pubitemid 29052951)
12. Chauhan, A. K., Li, Y. S., and Deuel, T. F. (1993) Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc. Natl. Acad. Sci. U.S.A. 90, 679-682 (Pubitemid 23028927)
13. Delbé, J., Vacherot, F., Laaroubi, K., Barritault, D., and Courty, J. (1995) Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J. Cell. Physiol. 164, 47-54
14. Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., and Wellstein, A. (1992) Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem. 267, 25889-25897 (Pubitemid 23013992)
15. Grzelinski, M., Steinberg, F., Martens, T., Czubayko, F., Lamszus, K., and Aigner, A. (2009) Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia 11, 145-156
16. Laaroubi, K., Delbé, J., Vacherot, F., Desgranges, P., Tardieu, M., Jaye, M., Barritault, D., and Courty, J. (1994) Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors 10, 89-98 (Pubitemid 24170020)
17. Park, T. J., Jeong, B. R., Tateno, C., Kim, H. S., Ogawa, T., Lim, I. K., and Yoshizato, K. (2008) Pleiotrophin inhibits transforming growth factor β1-induced apoptosis in hepatoma cell lines. Mol. Carcinog. 47, 784 -796
18. Zhang, N., Yeh, H. J., Zhong, R., Li, Y. S., and Deuel, T. F. (1999) A dominant- negative pleiotrophin mutant introduced by homologous recombination leads to germ-cell apoptosis in male mice. Proc. Natl. Acad. Sci. U.S.A. 96, 6734-6738 (Pubitemid 29274952)
19. Perez-Pinera, P., Alcantara, S., Dimitrov, T., Vega, J. A., and Deuel, T. F. (2006) Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc. Natl. Acad. Sci. U.S.A. 103, 17795-17800 (Pubitemid 44852239)
20. Chang, Y., Zuka, M., Perez-Pinera, P., Astudillo, A., Mortimer, J., Berenson, J. R., and Deuel, T. F. (2007) Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc. Natl. Acad. Sci. U.S.A. 104, 10888-10893 (Pubitemid 47175196)
21. Choudhuri, R., Zhang, H. T., Donnini, S., Ziche, M., and Bicknell, R. (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57, 1814-1819 (Pubitemid 27199678)
22. Zhang, N., Zhong, R., Perez-Pinera, P., Herradon, G., Ezquerra, L., Wang, Z. Y., and Deuel, T. F. (2006) Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch. Biochem. Biophys. Res. Commun. 343, 653-658
23. Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H., and Noda, M. (1996) 6B4 proteoglycan/phosphacan, an extracellular variant of receptor- like protein-tyrosine phosphatase ζ/RPTPβ, binds pleiotrophin/heparin- binding growth-associated molecule (HB-GAM). J. Biol. Chem. 271, 21446-21452 (Pubitemid 26293009)
24. Meng, K., Rodriguez-Peña, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., and Deuel, T. F. (2000) Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl. Acad. Sci. U.S.A. 97, 2603-2608 (Pubitemid 30159217)
25. Raulo, E., Chernousov, M. A., Carey, D. J., Nolo, R., and Rauvala, H. (1994) Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification asN-syndecan (syndecan-3). J. Biol. Chem. 269, 12999-13004
26. Levy, J. B., Canoll, P. D., Silvennoinen, O., Barnea, G., Morse, B., Honegger, A. M., Huang, J. T., Cannizzaro, L. A., Park, S. H., Druck, T., and (1993) The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J. Biol. Chem. 268, 10573-10581 (Pubitemid 23150247)
27. Maeda, N., and Noda, M. (1998) Involvement of receptor-like protein tyrosine phosphatase ζ/RPTPβ and its ligand pleiotrophin/heparin- binding growth-associated molecule (HB-GAM) in neuronal migration. J. Cell Biol. 142, 203-216 (Pubitemid 28341151)
28. Mentlein, R., and Held-Feindt, J. (2002) Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J. Neurochem. 83, 747-753 (Pubitemid 35316024)
29. Vanderwinden, J. M., Mailleux, P., Schiffmann, S. N., and Vanderhaeghen, J. J. (1992) Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anat. Embryol. 186, 387-406
30. Toba, Y., Horie, M., Sango, K., Tokashiki, A., Matsui, F., Oohira, A., and Kawano, H. (2002) Expression and immunohistochemical localization of heparan sulphate proteoglycan N-syndecan in the migratory pathway from the rat olfactory placode. Eur. J. Neurosci. 15, 1461-1473 (Pubitemid 35477976)
31. Papadimitriou, E., Heroult, M., Courty, J., Polykratis, A., Stergiou, C., and Katsoris, P. (2000) Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides. Biochem. Biophys. Res. Commun. 274, 242-248 (Pubitemid 30496786)
32. Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., Antipin, Y., Mitsiades, N., Landers, T., Dolgalev, I., Major, J. E., Wilson, M., Socci, N. D., Lash, A. E., Heguy, A., Eastham, J. A., Scher, H. I., Reuter, V. E., Scardino, P. T., Sander, C., Sawyers, C. L., and Gerald, W. L. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22
33. Hazan, R. B., Kang, L., Whooley, B. P., and Borgen, P. I. (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4, 399-411
34. Kang, Y., and Massagué, J. (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118, 277-279 (Pubitemid 39061108)
35. Gu, D., Yu, B., Zhao, C., Ye, W., Lv, Q., Hua, Z., Ma, J., and Zhang, Y. (2007) The effect of pleiotrophin signaling on adipogenesis. FEBS Lett. 581, 382-388 (Pubitemid 46164804)
36. Pariser, H., Perez-Pinera, P., Ezquerra, L., Herradon, G., and Deuel, T. F. (2005) Pleiotrophin stimulates tyrosine phosphorylation of β-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase β/ζ. Biochem. Biophys. Res. Commun. 335, 232-239 (Pubitemid 41350785)
37. Pariser, H., Herradon, G., Ezquerra, L., Perez-Pinera, P., and Deuel, T. F. (2005) Pleiotrophin regulates serine phosphorylation and the cellular distribution of β-adducin through activation of protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 102, 12407-12412 (Pubitemid 41266372)
38. Pariser, H., Ezquerra, L., Herradon, G., Perez-Pinera, P., and Deuel, T. F. (2005) Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase β/ζ-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem. Biophys. Res. Commun. 332, 664-669 (Pubitemid 40745166)
39. Kawachi, H., Fujikawa, A., Maeda, N., and Noda, M. (2001) Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase β/ζby the yeast substrate-trapping system. Proc. Natl. Acad. Sci. U.S.A. 98, 6593-6598 (Pubitemid 32538261)
40. Roskoski, R., Jr. (2004) Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324, 1155-1164
41. Gopalkrishnan, R. V., Kang, D. C., and Fisher, P. B. (2001) Molecular markers and determinants of prostate cancer metastasis. J. Cell. Physiol. 189, 245-256 (Pubitemid 33063292)
42. Diamantopoulou, Z., Bermek, O., Polykratis, A., Hamma-Kourbali, Y., Delbé, J., Courty, J., and Katsoris, P. (2010) A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ. Mol. Cancer 9, 224
43. Hatziapostolou, M., Delbe, J., Katsoris, P., Polytarchou, C., Courty, J., and Papadimitriou, E. (2005) Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate 65, 151-158 (Pubitemid 41362282)
44. Mailleux, P., Vanderwinden, J. M., and Vanderhaeghen, J. J. (1992) The new growth factor pleiotrophin (HB-GAM) mRNA is selectively present in the meningothelial cells of human meningiomas. Neurosci. Lett. 142, 31-35
45. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454
46. Thiery, J. P., and Sleeman, J. P. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (Pubitemid 43278296)
47. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F., Schaafsma, H. E., Debruyne, F. M., and Isaacs, W. B. (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in highgrade prostate cancer. Cancer Res. 52, 5104-5109
48. Umbas, R., Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G. O., Debruyne, F. M., and Schalken, J. A. (1994) Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 54, 3929-3933 (Pubitemid 24241218)
49. Lu, K. V., Jong, K. A., Kim, G. Y., Singh, J., Dia, E. Q., Yoshimoto, K., Wang, M. Y., Cloughesy, T. F., Nelson, S. F., and Mischel, P. S. (2005) Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J. Biol. Chem. 280, 26953-26964 (Pubitemid 41040731)
50. Ulbricht, U., Eckerich, C., Fillbrandt, R., Westphal, M., and Lamszus, K. (2006) RNA interference targeting protein tyrosine phosphatase ζ/receptor-type protein tyrosine phosphatase β suppresses glioblastoma growth in vitro and in vivo. J. Neurochem. 98, 1497-1506 (Pubitemid 44200441)
51. Yamakawa, T., Kurosawa, N., Kadomatsu, K., Matsui, T., Itoh, K., Maeda, N., Noda, M., and Muramatsu, T. (1999) Levels of expression of pleiotrophin and protein tyrosine phosphatase ζ are decreased in human colorectal cancers. Cancer Lett. 135, 91-96
52. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., and Bova, G. S. (1998) Interfocal heterogeneity of PTEN/ MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58, 204-209 (Pubitemid 28047054)
53. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617 (Pubitemid 28277707)
54. Gan, Y., Shi, C., Inge, L., Hibner, M., Balducci, J., and Huang, Y. (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29, 4947-4958
55. Li, J., Wei, H., Chesley, A., Moon, C., Krawczyk, M., Volkova, M., Ziman, B., Margulies, K. B., Talan, M., Crow, M. T., and Boheler, K. R. (2007) The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity. J. Biol. Chem. 282, 34984-34993 (Pubitemid 350232463)
56. Héroult, M., Bernard-Pierrot, I., Delbé, J., Hamma-Kourbali, Y., Katsoris, P., Barritault, D., Papadimitriou, E., Plouet, J., and Courty, J. (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23, 1745-1753 (Pubitemid 38445166)